Geode Capital Management
ABVC icon

Geode Capital Management’s ABVC BioPharma ABVC Stock Holding History

Geode Capital Management’s Portfolio ABVC Stock Details ABVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$360K Buy
228,042
+6,873
+3% +$8.56K ﹤0.01% 3719
2026
Q1 		$215K Buy
221,169
+18,804
+9% +$31.1K ﹤0.01% 3884
2025
Q4 		$431K Buy
202,365
+14,553
+8% +$39K ﹤0.01% 3642
2025
Q3 		$571K Buy
187,812
+77,313
+70% +$237K ﹤0.01% 3570
2025
Q2 		$246K Buy
110,499
+6,017
+6% +$8.19K ﹤0.01% 3805
2025
Q1 		$111K Buy
104,482
+25,197
+32% +$15.3K ﹤0.01% 4007
2024
Q4 		$46.8K Buy
79,285
+7,678
+11% +$4.28K ﹤0.01% 4253
2024
Q3 		$48.9K Buy
71,607
+16,382
+30% +$11.8K ﹤0.01% 4270
2024
Q2 		$42.7K Buy
55,225
+33,225
+151% +$34.1K ﹤0.01% 4311
2024
Q1 		$28.8K Buy
22,000
+2,520
+13% +$3.27K ﹤0.01% 4426
2023
Q4 		$22.6K Hold
19,480
– – ﹤0.01% 4496
2023
Q3 		$20.3K Buy
19,480
+5,552
+40% +$13.4K ﹤0.01% 4623
2023
Q2 		$71K Hold
13,928
– – ﹤0.01% 4434
2023
Q1 		$87.8K Hold
13,928
– – ﹤0.01% 4386
2022
Q4 		$87K Sell
13,928
-37
-0.3% -$273 ﹤0.01% 4442
2022
Q3 		$122K Buy
13,965
+8,973
+180% +$75.4K ﹤0.01% 4473
2022
Q2 		$52K Hold
4,992
– – ﹤0.01% 4765
2022
Q1 		$136K Hold
4,992
– – ﹤0.01% 4539
2021
Q4 		$169K Hold
4,992
– – ﹤0.01% 4553
2021
Q3 		$115K Buy
+4,992
New +$141K ﹤0.01% 4637

Other funds holding ABVC

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Geode Capital Management's ABVC Position: Q2 2026 in Review

Geode Capital Management increased its ABVC BioPharma (ABVC) stake by 3.1% in Q2 2026, buying an estimated $8.56K and bringing the position to 228,042 shares worth $360K. The position accounts for ﹤0.01% of the portfolio, ranked #3719.

Geode Capital Management first reported a position in ABVC in Q3 2021 and has held it in 20 quarters since. The position peaked at $571K in Q3 2025. 15 funds tracked by Wall St. Rank hold ABVC as of Q2 2026.

  • Geode Capital Management held 228,042 shares of ABVC BioPharma worth $360K as of Q2 2026.
  • Geode Capital Management bought 6,873 ABVC BioPharma shares in Q2 2026, an estimated $8.56K.
  • ABVC BioPharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #3719 holding.
  • Geode Capital Management first reported a position in ABVC BioPharma in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's ABVC BioPharma position peaked at $571K in Q3 2025.
  • 15 funds tracked by Wall St. Rank held ABVC BioPharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.